Literature DB >> 6574149

Fibroblast prostaglandin E2 synthesis. Persistence of an abnormal phenotype after short-term exposure to mononuclear cell products.

J H Korn.   

Abstract

Acquired abnormalities of connective tissue metabolism in inflammatory diseases often persist when lesional tissue is maintained in in vitro culture. Although connective tissue cells are exposed to inflammatory cell-derived mediators in vivo and such mediators have been shown to alter connective tissue cell behavior, it is unclear whether the persistence of metabolic defects in vitro could result from remote in vivo exposure to these mediators. An in vitro model was used to test whether transient exposure of normal fibroblasts to inflammatory mediators could lead to metabolic alterations that persist during in vitro culture. Short-term exposure of human foreskin fibroblasts in vitro to supernates of mitogen-activated peripheral blood mononuclear cells led to persistent abnormalities of prostaglandin E2 (PGE2) metabolism. Fibroblasts previously exposed to mononuclear cell products synthesized more than twice as much PGE2 when stimulated compared with similarly stimulated but previously unexposed control fibroblasts of the same strain. The enhanced PGE2 synthesis persisted for as long as 20 wk and 19 cell generations after the original exposure to mononuclear cell products. Exposure of fibroblast populations to mononuclear cell products may, thus, lead to metabolite alterations that are still evident after multiple cell generations.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6574149      PMCID: PMC436984          DOI: 10.1172/jci110873

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  16 in total

1.  Connective tissue activation. X. Current studies of the process and its mediators.

Authors:  C W Castor; R B Lewis
Journal:  Scand J Rheumatol Suppl       Date:  1975

2.  Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast.

Authors:  E C LeRoy
Journal:  J Clin Invest       Date:  1974-10       Impact factor: 14.808

3.  Abnormalities of connective tissue cells cultured from patients with rheumatoid arthritis. II. Defective regulation of hyaluronate and collagen formation.

Authors:  C W Castor; E L Dorstewitz; K Rowe; J C Ritchie
Journal:  J Lab Clin Med       Date:  1971-01

4.  Connective tissue activation. II. Abnormalities of cultured rheumatoid synovial cells.

Authors:  C W Castor
Journal:  Arthritis Rheum       Date:  1971 Jan-Feb

5.  Rheumatoid behavior in normal human synovial fibroblasts induced by extracts of Gram-negative bacteria.

Authors:  R B Buckingham; C W Castor
Journal:  J Lab Clin Med       Date:  1975-03

6.  Lymphocyte-mediated activation of fibroblast proliferation and collagen production.

Authors:  S M Wahl; L M Wahl; J B McCarthy
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

7.  Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells.

Authors:  J M Dayer; S M Krane; R G Russell; D R Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1976-03       Impact factor: 11.205

8.  Collagenase production by rheumatoid synovial cells: stimulation by a human lymphocyte factor.

Authors:  J M Dayer; R Graham; G Russell; S M Krane
Journal:  Science       Date:  1977-01-14       Impact factor: 47.728

9.  Fibroblast heterogeneity and prostaglandin regulation of subpopulations.

Authors:  S D Ko; R C Page; A S Narayanan
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

10.  Prostaglandin production by rheumatoid synovial cells: stimulation by a factor from human mononuclear Cells.

Authors:  J M Dayer; D R Robinson; S M Krane
Journal:  J Exp Med       Date:  1977-05-01       Impact factor: 14.307

View more
  14 in total

1.  Heterogeneity in hormone responses and patterns of collagen synthesis in cloned dermal fibroblasts.

Authors:  S R Goldring; M L Stephenson; E Downie; S M Krane; J H Korn
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

2.  Augmentation of fibroblast proliferation by bleomycin.

Authors:  P L Moseley; C Hemken; G W Hunninghake
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

3.  Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-beta in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice.

Authors:  C B Keerthisingam; R G Jenkins; N K Harrison; N A Hernandez-Rodriguez; H Booth; G J Laurent; S L Hart; M L Foster; R J McAnulty
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

4.  Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients.

Authors:  R Stratton; X Shiwen; G Martini; A Holmes; A Leask; T Haberberger; G R Martin; C M Black; D Abraham
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

5.  Airway remodeling in murine asthma correlates with a defect in PGE2 synthesis by lung fibroblasts.

Authors:  Camila Leindecker Stumm; Scott H Wettlaufer; Sonia Jancar; Marc Peters-Golden
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-08-26       Impact factor: 5.464

6.  Severity of lung injury in cyclooxygenase-2-deficient mice is dependent on reduced prostaglandin E(2) production.

Authors:  Rebecca J Hodges; R Gisli Jenkins; Caroline P D Wheeler-Jones; Danielle M Copeman; Stephen E Bottoms; Geoffrey J Bellingan; Carmel B Nanthakumar; Geoffrey J Laurent; Stephen L Hart; Martyn L Foster; Robin J McAnulty
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

7.  Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2.

Authors:  J Wilborn; L J Crofford; M D Burdick; S L Kunkel; R M Strieter; M Peters-Golden
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression.

Authors:  Fei Liu; Justin D Mih; Barry S Shea; Alvin T Kho; Asma S Sharif; Andrew M Tager; Daniel J Tschumperlin
Journal:  J Cell Biol       Date:  2010-08-23       Impact factor: 10.539

9.  Altered Cyclooxygenase-2 Expression in Pulmonary Sarcoidosis is not Related to Clinical Classifications.

Authors:  Justyna Kiszałkiewicz; Wojciech J Piotrowski; Dorota Pastuszak-Lewandoska; Paweł Górski; Adam Antczak; Witold Górski; Daria Domańska-Senderowska; Monika Migdalska-Sęk; Karolina H Czarnecka; Ewa Nawrot; Ewa Brzeziańska-Lasota
Journal:  Inflammation       Date:  2016-08       Impact factor: 4.092

10.  Arterial eicosanoid production following chronic exposure to a periarterial haematoma.

Authors:  J D Pickard; V Walker; S Perry; P J Smythe; S Eastwood; R Hunt
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-07       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.